Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-24-006336
Filing Date
2024-11-13
Accepted
2024-11-13 15:12:02
Documents
44
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xbit20240930_10q.htm   iXBRL 10-Q 750116
2 EXHIBIT 31.1 ex_742444.htm EX-31.1 11287
3 EXHIBIT 31.2 ex_742445.htm EX-31.2 11413
4 EXHIBIT 32.1 ex_742446.htm EX-32.1 8230
  Complete submission text file 0001171843-24-006336.txt   3438604

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xbit-20240930.xsd EX-101.SCH 26620
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbit-20240930_def.xml EX-101.DEF 198793
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20240930_lab.xml EX-101.LAB 203291
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20240930_pre.xml EX-101.PRE 221417
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbit-20240930_cal.xml EX-101.CAL 25879
47 EXTRACTED XBRL INSTANCE DOCUMENT xbit20240930_10q_htm.xml XML 427220
Mailing Address 5217 WINNEBAGO LANE AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 241453488
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)